merged_exthera-cancer-blood-filtering-device.txt
<question_1>1</question_1>
<answer>N/A</answer>
<question_2>2</question_2>
<answer>N/A</answer>
<question_3>3</question_3>
<answer>N/A</answer>
<question_4>4</question_4>
<answer>N/A</answer>
<question_5>5</question_5>
<answer>N/A</answer>
<question_6>6</question_6>
<answer>The government in Antigua had authorized Mr. Quasha's firm to use the device on cancer patients, unlike the F.D.A.</answer>
<question_7>7</question_7>
<answer>tumor lysis syndrome</answer>
<question_8>8</question_8>
<answer>71 percent</answer>
<question_9>9</question_9>
<answer>three</answer>
<question_10>10</question_10>
<answer>Seraph 100 Microbind Affinity Blood Filter</answer>
<question_11>11</question_11>
<answer>F.D.A.</answer>
<question_12>12</question_12>
<answer>valve</answer>
<question_13>13</question_13>
<answer>Two</answer>
<question_14>14</question_14>
<answer>heparin</answer>
<question_15>15</question_15>
<answer>$10 million</answer>
<question_16>16</question_16>
<answer>dialysis machine</answer>
<question_17>17</question_17>
<answer>five</answer>